Literature DB >> 2916370

Grave's disease. Appearance in cytologic smears from fine needle aspirates of the thyroid gland.

G Jayaram1, B Singh, R K Marwaha.   

Abstract

The cytomorphologic features were analyzed in thyroid samples obtained by fine needle aspiration (FNA) from 54 cases proven to be Grave's disease (toxic goiter) by a multiparameter study. A fire-flare appearance of the follicular cells and a good cellularity of the smears were the features most frequently observed in these cases. Hürthle cell changes were present in 47% of the cases, and small numbers of lymphocytes were seen in smears from 41% of the cases. Epithelioid cell granulomata and multinucleated giant cells were observed in less than one-fourth of the cases. About half of the cases showed some degree of pleomorphism of the follicular cells. Twenty cases of toxic multinodular goiter were similarly analyzed; the features that distinguished this entity from Grave's disease were the absence of epithelioid cells and multinucleated giant cells in the FNA smears.

Entities:  

Mesh:

Year:  1989        PMID: 2916370

Source DB:  PubMed          Journal:  Acta Cytol        ISSN: 0001-5547            Impact factor:   2.319


  3 in total

1.  Hyperthyroidism of Graves' disease: evidence for only unilateral involvement of the thyroid gland in a 31-year-old female patient.

Authors:  H P Dimai; S Ramschak-Schwarzer; S Lax; R W Lipp; G Leb
Journal:  J Endocrinol Invest       Date:  1999-03       Impact factor: 4.256

2.  The National Cancer Institute Thyroid fine needle aspiration state of the science conference: a summation.

Authors:  Zubair W Baloch; Edmund S Cibas; Douglas P Clark; Lester J Layfield; Britt-Marie Ljung; Martha Bishop Pitman; Andrea Abati
Journal:  Cytojournal       Date:  2008-04-07       Impact factor: 2.091

3.  Cytomorphologic significance of marginal vacuoles in diffuse thyroid enlargements.

Authors:  Anshu Gupta; Manish Singhal; Shivani Kalhan; Atul Gupta; Onis Singhal; Viplesh Kaur
Journal:  J Cytol       Date:  2013-04       Impact factor: 1.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.